EFFECTIVENESS OF THE SYSTEMATIC MEDIASTINAL BILATERAL LYMPH DISSECTION IN THE SURGICAL TREATMENT OF LUNG CARCINOMA

A. V. Tchernyh

I.P. Pavlov Russian Medical Biological Herald ›› 2009, Vol. 17 ›› Issue (1) : 121 -127.

PDF
I.P. Pavlov Russian Medical Biological Herald ›› 2009, Vol. 17 ›› Issue (1) :121 -127. DOI: 10.17816/PAVLOVJ20164164-172
Clinical and experimental oncology
research-article

EFFECTIVENESS OF THE SYSTEMATIC MEDIASTINAL BILATERAL LYMPH DISSECTION IN THE SURGICAL TREATMENT OF LUNG CARCINOMA

Author information +
History +
PDF

Abstract

The systematic lymph dissection, a drastic treatment procedure in the surgical treatment of lung carcinoma, is declared to be an operative procedure helping to assess the true extent of a neoplastic [tumor] process. From the 300 operative interventions the 150 (50,0%) came to “expanded” operations which were followed by a systematic lymph dissection from principal considerations. The other 150 (50,0%) patients were operated typically without any systematic mediastinal lymph dissection. The general five-year probability of survival (equal to 30%), while the postoperative lethality is equal to 6,7%, speaks for a surgical assistance of a good quality in the clinical hospital. To present day 254 (85,0% from the 300) patients have been watched over.

Cite this article

Download citation ▾
A. V. Tchernyh. EFFECTIVENESS OF THE SYSTEMATIC MEDIASTINAL BILATERAL LYMPH DISSECTION IN THE SURGICAL TREATMENT OF LUNG CARCINOMA. I.P. Pavlov Russian Medical Biological Herald, 2009, 17(1): 121-127 DOI:10.17816/PAVLOVJ20164164-172

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1.Давыдов М. И. Принципы хирургического лечения злокачественных опухолей в торакоабдоминальной клинике// Вопросы онкологии. — 2002. - Т. 48, №4—5. - С. 468-479.

[2]

2.Давыдов М. И., Полоцкий Б. Е. Рак легкого. — М.: Радикс.1994. -210с.

[3]

3.Трахтенберг А. X. Рак легкого.-М.,1987. -303 с.

[4]

4.De Pierre A., Milleron В., Moro-Sibi/ot D. et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectablestage I (except T1N0), II and 111A non-small-cell lung cancer. //J. ClinOncol. - 2002. - №20. - P. 247-253.

[5]

5.Pass H.,Mitchell J.,Johnson D.et al. Lung cancer. Principles and Practice.-Raven,1996.-982 p.

RIGHTS & PERMISSIONS

Tchernyh A.V.

PDF

128

Accesses

0

Citation

Detail

Sections
Recommended

/